Novo Nordisk A/S

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DK0062498333
DKK
309.60
5.8 (1.91%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Novo Nordisk A/S Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
127,208.00
104,593.00
69,251.00
59,104.00
52,981.00
48,690.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-11,995.00
-12,245.00
-5,336.00
-8,656.00
-4,353.00
-3,388.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
120,968.00
108,908.00
78,887.00
55,004.00
51,969.00
46,802.00
Cash Flow from Investing Activities
-128,895.00
-43,892.00
-24,918.00
-31,609.00
-22,454.00
-11,529.00
Cash Flow from Financing Activities
8,735.00
-63,158.00
-51,797.00
-25,493.00
-32,244.00
-35,484.00
Net Cash Inflow / Outflow
1,263.00
1,739.00
1,934.00
-1,507.00
-3,185.00
-218.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
455.00
-119.00
-238.00
591.00
-456.00
-7.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in DKK Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Novo Nordisk A/S
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(DKK)
Change(%)
Profit Before Tax
127208
9164
1,18,044.00
1288.13%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-11995
-738
-11,257.00
-1525.34%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
120968
7771
1,13,197.00
1456.66%
Cash Flow from Investing Activities
-128895
-9907
-1,18,988.00
-1201.05%
Cash Flow from Financing Activities
8735
-3919
12,654.00
322.89%
Net Cash Inflow / Outflow
1263
-5009
6,272.00
125.21%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
455
1046
-591.00
-56.50%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 11.07% vs 38.06% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
1,20,968.00
1,08,908.00
11.07%